Diprivan and Dyslipidaemia - a phase IV clinical study of FDA data

Summary:

Dyslipidaemia is reported as a side effect among people who take Diprivan (propofol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Colace, and have Diabetes.

The phase IV clinical study analyzes which people have Dyslipidaemia when taking Diprivan. It is created by eHealthMe based on reports of 6,477 people who have side effects when taking Diprivan from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Dyslipidaemia?

Dyslipidaemia (abnormal amount of lipids) is found to be associated with 836 drugs and 711 conditions by eHealthMe. Check the latest studies of Dyslipidaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

6,477 people reported to have side effects when taking Diprivan.
Among them, 12 people (0.19%) have Dyslipidaemia.

Among these 12 people:

How long have people been on Diprivan when they have Dyslipidaemia? *

What is the gender of people who have Dyslipidaemia when taking Diprivan? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Dyslipidaemia when taking Diprivan? *

What are other drugs people take besides Diprivan? *

Pepcid: 11 people, 91.67%
Zantac: 11 people, 91.67%
Colace: 11 people, 91.67%
Percocet: 9 people, 75.00%
Zemuron: 9 people, 75.00%
Meperidine Hydrochloride: 9 people, 75.00%
Lidocaine: 9 people, 75.00%
Robinul: 9 people, 75.00%
Zometa: 9 people, 75.00%
Ephedrine Sulfate: 9 people, 75.00%

What are other side effects people have besides Dyslipidaemia? *

Nausea (feeling of having an urge to vomit): 11 people, 91.67%
Weakness: 10 people, 83.33%
Diabetes: 10 people, 83.33%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 9 people, 75.00%
Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 9 people, 75.00%
Mitral Valve Incompetence (inefficient heart valve): 9 people, 75.00%
Anaemia (lack of blood): 9 people, 75.00%
Oral Herpes (viral infection of mouth): 9 people, 75.00%
Pain: 9 people, 75.00%
Belching (release of gas from the digestive tract): 9 people, 75.00%

What are the existing conditions these people have? *

Ill-Defined Disorder: 2 people, 16.67%
Diabetes: 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
Bone Disorder: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and have Dyslipidaemia?

- Check whether Dyslipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diprivan:

Diprivan (6,496 reports)

Dyslipidaemia treatments and more:

Dyslipidaemia (42,009 reports)

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyslipidaemia:

Dyslipidaemia (836 drugs)

Browse all the conditions that are associated with Dyslipidaemia:

Dyslipidaemia (711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on propofol (the active ingredients of Diprivan) and Diprivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.